The influence of neoadjuvant chemotherapy of patients with colorectal cancer in immune function and tumor markers

doi:10.3877/cma.j.issn.2095-3224.2015.04.13

Abstract

Abstract:

Objective

To investigate the effects of neoadjuvant chemotherapy of stage II, III retal cancer on immune function and tumor markers.

Methods

To analyze 31 cases patients with rectal cancer of neoadjuvant chemotherapy, and monitor the tumor markers and immune function before and after chemotherapy.

Results

The comparison of CEA(P=0.049), CA242(P=0.048)levels between before and after chemotherapy in these 31 patients had significant difference; while CA199 has no significant difference(P=0.252). Only B cells immune function had significant difference(P=0.044), the rest of the total T cells, helper T cells, cytotoxic T cells, natural killer cells, CD4/CD8, or regulatory T cells showed no significant difference.

Conclusion

neoadjuvant chemotherapy can significantly reduce levels of CEA, CA242 patients in II, III stage rectal cancer; and had no effect on cellular immune function, only decreased B cell function.

Key words: Rectal cancer, Neoadjuvant chemotherapy, Tumor marker, Immune function

Yi-xun ZHANG, Yao-ping LI, Bo JIANG, Hai-yi LIU, Sheng-huai HOU, Yan-jun LU, Hai-bo WANG. The influence of neoadjuvant chemotherapy of patients with colorectal cancer in immune function and tumor markers[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2015, 04(04): 411-414.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjzcjbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3224.2015.04.13

https://zhjzcjbdzzz.cma-cmc.com.cn/EN/Y2015/V04/I04/411

Figures/Tables 2

References 13

[1]	Minsky BD, Sphincher preservation in rectal cancer.Preoperative radiation therapy followed by low anterior resection with coloanal anastomosis.Semin Radiat Oncol, 1998, 8(1): 30-35.
[2]	Baxter NN, Garcia-Aguilar J. Organ preservation for rectal cancer.J Clin Oncol, 2007, 25(8): 1014-1020.
[3]	Ros MS, Colangelo LH, O’Connell MJ, et al.Preoperative multimodality therapy improves disease-free survival in patients with careinoma of the rectum: NSABP R-03.J Clin Oncol, 2009, 27(31): 5124-5130.
[4]	詹天成，李明，顾晋．解读美国结直肠癌外科医师协会2013直肠癌治疗指南．中华胃肠外科杂志，2013，16(8): 701-709.
[5]	姚宏伟，刘荫华．从NCCN临床实践指南更新看直肠癌外科个体化治疗的进步．中华外科杂志，2012，50(3): 196-199.
[6]	Lai LL, Fuller CD, Kachnic LA, et alCan pelvic radiotherapy be omitted in select patients with rectal cancer？.Semin Oncol, 2006, 33(11): 70-74.
[7]	Peeters KC, vande Velde CJ, Leer JW, et al.Late side effects of short-course preoperative radiotherapy combined with total mesoreactal excision for rectal cancer: increased bowel dysfunction in irradiated patients-a Dutch colorectal cancer group study.J Clin Oncol, 2005, 23(25): 6199-6206.
[8]	Madoff RDChemoradiotherapy for rectal cancer-when, why, and how？.N Engl J Med, 2004, 351(17): 1790-1792.
[9]	陶凯雄，帅小明．中低位直肠癌的规范化治疗．中华胃肠外科杂志，2013，16(6): 518-520.
[10]	Collette L, Bosset JF, den Dulk M, et al.Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy？A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.J Clin Oncol, 2007, 25(28): 4379-4386.
[11]	Park IJ, You YN, Agarwal A, et al.Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.J Clin Oncol, 2012, 30(15)1770-1776.
[12]	Sliberfein EJ, Kattepoqu KM, Hu CY, et al.Long-term survival and recurrence outcomes following surgery for distal rectal cancer.Ann Surg Oncol, 2010, 17(11): 2863-2869.
[13]	Smith KD, Tan D, Das P, et al.Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation.Ann Surg, 2010, 251(2): 261-264.

?	0度	I度	II度	III度
消化道反应	5	18	7	1
骨髓抑制	13	17	1	0
肝功能	18	13	0	0
周围神经	3	26	2	0

?	0度	I度	II度	III度
消化道反应	5	18	7	1
骨髓抑制	13	17	1	0
肝功能	18	13	0	0
周围神经	3	26	2	0

组别	新辅助化疗前	新辅助化疗后	F	P
CEA	33.52±6.02	8.54±15.88	4.048	0.049
CA199	74.64±131.75	40.54±97.73	1.340	0.252
CA242	67.11±103.78	26.60±41.09	4.083	0.048
CD4＋CD8＋T细胞	69.23±11.39	72.34±9.22	1.399	0.242
CD4＋T细胞	36.28±7.5	38.14±10.03	0.682	0.412
CD8＋T细胞	28.53±7.85	31.21±8.62	1.640	0.205
CD4/CD8	1.36±0.43	1.40±0.85	0.077	0.782
NK细胞	20.42±10.45	18.56±9.88	0.517	0.475
调节性T细胞	6.37±2.25	5.81±1.41	1.402	0.241
B细胞	9.67±3.77	7.70±3.78	4.224	0.044

组别	新辅助化疗前	新辅助化疗后	F	P
CEA	33.52±6.02	8.54±15.88	4.048	0.049
CA199	74.64±131.75	40.54±97.73	1.340	0.252
CA242	67.11±103.78	26.60±41.09	4.083	0.048
CD4＋CD8＋T细胞	69.23±11.39	72.34±9.22	1.399	0.242
CD4＋T细胞	36.28±7.5	38.14±10.03	0.682	0.412
CD8＋T细胞	28.53±7.85	31.21±8.62	1.640	0.205
CD4/CD8	1.36±0.43	1.40±0.85	0.077	0.782
NK细胞	20.42±10.45	18.56±9.88	0.517	0.475
调节性T细胞	6.37±2.25	5.81±1.41	1.402	0.241
B细胞	9.67±3.77	7.70±3.78	4.224	0.044

[1]	Wei Hong, Xirong Ye, Zhihong Liu, Yinfeng Yang, Zhihong Lyu. Value of ultrasound radiomics combined with clinicopathological features in predicting complete pathological response to neoadjuvant chemotherapy for breast cancer [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(06): 571-579.
[2]	Jie Xu, Yajun Li, Yiwen Feng. Comparison of recent follow-up between laparoscopic D2 radical surgery and conventional radical surgery for advanced gastric cancer after SOX neoadjuvant chemotherapy [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 647-650.
[3]	Chaojun Zhang, Xinpu Yuan. Laparoscopic assisted radical resection of low rectal cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 602-602.
[4]	Zun Chen, Ping Wang, Hua Jin, Meiling Zhou, Qingqing Li, Yonggang Huang. Application of sarcopenia in predicting incisional hernia after colorectal cancer surgery [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(06): 639-644.
[5]	Xiaopeng Chen, Jiani Wang, Qinghai Lian, Jiumei Yang. Expression of VOPP1 in hepatocellular carcinoma and its relationship with prognosis [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 876-882.
[6]	Jiagang Han, Zhenjun Wang. The treatment strategies for obstructive left-sided colon cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 450-458.
[7]	Yang Shi, Jianfeng Yu, Ke Cao, Zhiwei Zhai, Chunxiang Ye, Zhenjun Wang, Jiagang Han. Perioperative complication analysis of self-expanding metallic stents （sems） combined with neoadjuvant chemotherapy in the treatment of complete obstructive left-sided colon cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 464-471.
[8]	Xuanhao Liang, Xiaorong Li, Liang Li, Changwei Lin. Efficacy and prognosis of colonic stenting combined with neoadjuvant chemotherapy for acute obstructive colorectal cancer： a Meta-analysis [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 472-482.
[9]	Hongxia Yan, Xiaojuan Wang, Yixun Zhang. The effect of type 2 diabetes on tumor markers， clinicopathology and prognosis in patients with colorectal cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 483-487.
[10]	Guoqiang Wang, Gang Zhang, Jianpo Tang, Yuguo Zhang, Yongjiang Yang. Effects of LINC00839 on proliferation，apoptosis，and migration of colorectal cancer cells by regulating the miR-17-5p/WEE1 axis [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(06): 491-499.
[11]	Han Sun, Bing Yu, Xia Wu, Xilang Zhou. Construction and validation of a predictive model for screening of colorectal cancer based on circulating tumor DNA methylation [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(06): 500-506.
[12]	Qianqian Chen, Chen Yuan, Ji Liu, Tingting Yin. Effects of multi-slice spiral CT parameters，carcinoembryonic antigen，mismatch repair gene，and pathological indicators on prognosis of colorectal cancer [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(06): 507-511.
[13]	Zhan Wang, Wenkun Li, Yi Yang, Fang Xu, Minsi Zhou, Jiayi Su, Yadan Wang, Jing Wu. Application of inflammatory markers in early-onset colorectal tumors [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(09): 802-810.
[14]	Fucheng Liu, Xin Zhao, Haipeng Qiao, Xiaofeng Liu, Chong Zhang, Zongming Zhang. Effect of left colic artery-preserving lymph node dissection at the root of the inferior mesenteric artery [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(07): 647-653.
[15]	Mengting Zhang, Lamu Qiong, Zhen Se, Yiqun Li, Wangmu DeQing. Neoadjuvant chemotherapy for breast cancer patients in Tibet: a real-world study [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(05): 441-446.

Please choose a citation manager

Content to export